Miguel Saceda
Elche, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Role of p38 MAPK in the cytokine reprogramming of a human leukemic cell line with a drug-resistant phenotype.
Journal: Cell communication and signaling : CCS
Published: July 10, 2025
Electrospun PMVEMA Nanofibers Developed as a Fast-Release Platform for Antineoplastic Drugs Tested in Glioblastoma Primary Cultures.
Journal: Pharmaceutics
Published: July 07, 2025
Insights into histone deacetylase inhibitors-induced cell death in cancer cell lines.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2025
Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 30, 2024
Identification of new targets for glioblastoma therapy based on a DNA expression microarray.
Journal: Computers in biology and medicine
Published: March 08, 2024
The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells.
Journal: International journal of biological macromolecules
Published: April 05, 2023
Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment.
Journal: International journal of molecular sciences
Published: March 09, 2023
New therapy for pancreatic cancer based on extracellular vesicles.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 24, 2023
Biomedical application of small extracellular vesicles in cancer treatment.
Journal: Advanced drug delivery reviews
Published: September 10, 2021
CLytA-DAAO Chimeric Enzyme Bound to Magnetic Nanoparticles. A New Therapeutical Approach for Cancer Patients?
Journal: International journal of molecular sciences
Published: December 31, 2020
Last Updated: 09/26/2026